新光药业
(300519)
| 流通市值：13.84亿 | | | 总市值：19.41亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 100,545,259.3 | 270,399,837.67 | 216,113,933.59 | 149,038,556.1 |
| 营业收入 | 100,545,259.3 | 270,399,837.67 | 216,113,933.59 | 149,038,556.1 |
| 二、营业总成本 | 76,153,559.49 | 203,773,231.62 | 151,115,999.35 | 107,244,807.17 |
| 营业成本 | 62,812,898.25 | 158,795,336.02 | 118,607,504.24 | 79,114,351.32 |
| 税金及附加 | 1,645,256.87 | 4,361,787.75 | 2,366,744.8 | 1,682,178.16 |
| 销售费用 | 5,961,742.51 | 26,454,267.67 | 18,355,326.27 | 12,780,466.14 |
| 管理费用 | 3,676,940.35 | 17,918,334.79 | 13,089,410.64 | 8,710,186.42 |
| 研发费用 | 3,945,710.79 | 15,134,245.96 | 11,763,165.15 | 7,673,241.07 |
| 财务费用 | -1,888,989.28 | -18,890,740.57 | -13,066,151.75 | -2,715,615.94 |
| 其中:利息收入 | 1,892,311.55 | - | 13,077,437.34 | 2,724,347.82 |
| 加:投资收益 | 1,095,815.46 | 4,072,720.41 | 3,174,277.63 | 2,025,988.1 |
| 资产处置收益 | -67,847.01 | -290,571.95 | 12,998.27 | 12,998.27 |
| 资产减值损失(新) | -377,437.08 | -503,339.21 | -483,944.28 | -606,474.27 |
| 信用减值损失(新) | 121,762.8 | 708,142.15 | 367,107.11 | 604,901.64 |
| 其他收益 | 844,197.51 | 3,519,474.93 | 2,009,664.82 | 1,503,305.62 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 26,008,191.49 | 74,133,032.38 | 70,078,037.79 | 45,334,468.29 |
| 加:营业外收入 | 188,474 | 31,243.46 | 8,000 | 8,000 |
| 减:营业外支出 | 6,700 | 1,004,171.5 | 1,000,000 | - |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 26,189,965.49 | 73,160,104.34 | 69,086,037.79 | 45,342,468.29 |
| 减:所得税费用 | 3,359,624.13 | 8,803,623.69 | 10,386,268.41 | 6,802,801.29 |
| 六、净利润 | 22,830,341.36 | 64,356,480.65 | 58,699,769.38 | 38,539,667 |
| 持续经营净利润 | 22,830,341.36 | 64,356,480.65 | 58,699,769.38 | 38,539,667 |
| 归属于母公司股东的净利润 | 22,830,341.36 | 64,356,480.65 | 58,699,769.38 | 38,539,667 |
| (一)基本每股收益 | 0.14 | 0.4 | 0.37 | 0.24 |
| (二)稀释每股收益 | 0.14 | 0.4 | 0.37 | 0.24 |
| 八、其他综合收益 | -407,242.18 | 869,736.31 | 429,698.86 | 334,440.27 |
| 归属于母公司股东的其他综合收益 | -407,242.18 | 869,736.31 | 429,698.86 | 334,440.27 |
| 九、综合收益总额 | 22,423,099.18 | 65,226,216.96 | 59,129,468.24 | 38,874,107.27 |
| 归属于母公司股东的综合收益总额 | 22,423,099.18 | 65,226,216.96 | 59,129,468.24 | 38,874,107.27 |
| 公告日期 | 2024-04-26 | 2024-04-22 | 2023-10-25 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |